Veru (VERU) EBITDA Margin (2009 - 2024)
Veru's EBITDA Margin was -150.59% in fiscal Q4 2024 (quarter ended Sep 30, 2024), up 58.43 percentage points from -209.03% a year earlier and up 114.47 percentage points from the prior quarter.
Powered by 
Analysis
Veru (VERU) EBITDA Margin (2009 - 2024) Analysis & Trends
For FY2024 (ended Sep 30, 2024), EBITDA Margin at Veru came in at -216.05%, up 356.91 percentage points from FY2023.
- EBITDA Margin shows a five-year change of -197.29 percentage points (FY2019 to FY2024).
- In earlier fiscal years, EBITDA Margin was -572.95% in FY2023 (-361.34 pp), -211.61% in FY2022 (-233.13 pp), 21.52% in FY2021 (+54.32 pp) and -32.79% in FY2020 (-14.04 pp).
- The fiscal Q4 2024 figure marks the highest quarterly EBITDA Margin since fiscal Q2 2022.
- Compared with a year earlier, EBITDA Margin has increased for five straight quarters, with an average year-over-year change of +140.21 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was fiscal Q4 2023 (a gain of 1524.50 percentage points); the worst was fiscal Q4 2022 (a drop of 1721.83 percentage points).
- Per Business Quant data, VERU's EBITDA Margin in the three fiscal quarters before Q4 2024 was -265.07% (Q3 2024), -213.36% (Q2 2024) and -334.25% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Veru | 48.87 Mn | -61.41 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -227.09% |
| Jun 30, 2024 | -265.07% |
| Mar 31, 2024 | -213.36% |
| Dec 31, 2023 | -334.25% |
| Sep 30, 2023 | -209.03% |
| Jun 30, 2023 | -408.22% |
| Mar 31, 2023 | -521.55% |
| Dec 31, 2022 | -1,491.02% |
| Sep 30, 2022 | -1,733.53% |
| Jun 30, 2022 | -226.69% |
| Mar 31, 2022 | -89.94% |
| Dec 31, 2021 | -34.80% |
| Sep 30, 2021 | -11.70% |
| Jun 30, 2021 | -16.04% |
| Mar 31, 2021 | -10.73% |
| Dec 31, 2020 | 131.89% |
| Sep 30, 2020 | -94.26% |
| Jun 30, 2020 | -8.17% |
| Mar 31, 2020 | -1.06% |
| Dec 31, 2019 | -15.02% |
API Access
Veru EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();